”One-Pot Multicomponent Neat Synthesis of New Designed Naphtho[2,3-d]thiazole Derivatives: Antimicrobial Activity, DFT Analysis, and ADMET Studies”

Authors:

Abstract
Antibiotic resistance has emerged as a serious global public health concern, and the urgent need to develop new antibacterial drugs with improved therapeutic potential. Naphthothiazole-based antibacterial agents have gained significant interest due to their membrane-targeting mechanisms. Herein, a series of naphthothiazole derivatives were designed, synthesized via one-pot multi-component neat synthesis and evaluate their antibacterial activity against Gram-positive Staphylococcus aureus and Gram-negative Pseudomonas aeruginosa bacteria, as well as their toxicity against RBCs. Among the 14 synthesized compounds, 4h and 4l exhibited the best antimicrobial activity, with a minimum inhibitory concentration (MIC) of 1 μg/mL against Pseudomonas aeruginosa and 4 μg/mL and 1 μg/mL against Staphylococcus aureus, respectively. These compounds kill the bacteria via reactive oxygen species (ROS) generation and by inhibiting the biofilm formations. Molecular docking studies against penicillin-binding protein 2a (PBP2a) of Staphylococcus aureus (PDB ID: 1VQQ), supported the interaction of 4h and 4l with the active site of the protein. Additionally, 4h and 4l significantly decreased cell viability and biofilm formation at lower concentrations. ADMET studies also indicate drug-like properties. Thus, we identified 4h and 4l as lead compounds with strong antibacterial activity.